Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance
Language English Country Slovakia Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- CD56 Antigen analysis MeSH
- Antigens, CD19 analysis MeSH
- ADP-ribosyl Cyclase 1 analysis MeSH
- Adult MeSH
- Phenotype MeSH
- Middle Aged MeSH
- Humans MeSH
- Multiple Myeloma diagnosis immunology MeSH
- Paraproteinemias diagnosis immunology MeSH
- Plasma Cells pathology MeSH
- Prognosis MeSH
- Flow Cytometry MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Syndecan-1 analysis MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- CD56 Antigen MeSH
- Antigens, CD19 MeSH
- ADP-ribosyl Cyclase 1 MeSH
- Syndecan-1 MeSH
Flow cytometry is a useful tool for the analysis of plasma cells in monoclonal gammopathies. The aim of this study was to find possibilities and limits of multicolour flow cytometry in diagnostics of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) and to identify parameters that could be used to differentiate between these two disorders. Surface markers CD38 and CD138 were used for identification of plasma cells, CD19 and CD56 further distinguished normal and abnormal plasma cells, respectively. The percentage of circulating plasma cells in peripheral blood was lower in MGUS patients then in MM (p<0,001) In bone marrow, the percentage of residual polyclonal CD19 plasma cell was higher (p<0,001) and the percentage of malignant monoclonal CD56 plasma cell was lower (p<0,001) in MGUS than in MM. In conclusion, flow cytometry is relatively quick and effective method for analysis of plasma cells thus immunophenotyping can significantly contribute to the differential diagnosis of plasma cell proliferations.
References provided by Crossref.org
